ASSET | DATE | % RETURN |
---|---|---|
Terawulf (WULF) | 6/1/2024 - 6/13/2024 | 80.89% |
Iris Energy (IREN) | 6/1/2024 - 6/13/2024 | 66.16% |
Bitdeer Technologies Group Class A Ordinary Shares (BTDR) | 6/1/2024 - 6/13/2024 | 61.48% |
QXO (QXO) | 6/1/2024 - 6/13/2024 | 58.05% |
Avidity Biosciences (RNA) | 6/1/2024 - 6/13/2024 | 47.62% |
GeneDx (WGS) | 6/1/2024 - 6/13/2024 | 40% |
Geron (GERN) | 6/1/2024 - 6/13/2024 | 32.97% |
Hut 8 Corp Common Stock (HUT) | 6/1/2024 - 6/13/2024 | 28.6% |
Arm Holdings plc American Depositary Shares (ARM) | 6/1/2024 - 6/13/2024 | 26.44% |
Neogen (NEOG) | 6/1/2024 - 6/13/2024 | 25.76% |
Ast Spacemobile (ASTS) | 6/1/2024 - 6/13/2024 | 24.13% |
Broadcom (AVGO) | 6/1/2024 - 6/13/2024 | 24.12% |
Verona Pharma PLC ADR (VRNA) | 6/1/2024 - 6/13/2024 | 23.69% |
Texas Pacific Land Trust (TPL) | 6/1/2024 - 6/13/2024 | 23.56% |
Axcelis Technologies (ACLS) | 6/1/2024 - 6/13/2024 | 22.76% |
Twist Bioscience (TWST) | 6/1/2024 - 6/13/2024 | 22.05% |
Hims Hers Health (HIMS) | 6/1/2024 - 6/13/2024 | 21.97% |
Rhythm Pharmaceuticals (RYTM) | 6/1/2024 - 6/13/2024 | 21.9% |
Hewlett Packard Enterprise (HPE) | 6/1/2024 - 6/13/2024 | 21.5% |
Protagonist Therapeutics (PTGX) | 6/1/2024 - 6/13/2024 | 20.44% |
Nuvalent (NUVL) | 6/1/2024 - 6/13/2024 | 20.21% |
Crowdstrike (CRWD) | 6/1/2024 - 6/13/2024 | 19.86% |
Crispr Therapeutics (CRSP) | 6/1/2024 - 6/13/2024 | 19.04% |
Oracle (ORCL) | 6/1/2024 - 6/13/2024 | 18.99% |
DXC Technology (DXC) | 6/1/2024 - 6/13/2024 | 18.87% |